Growth Metrics

Fulgent Genetics (FLGT) Change in Receivables (2016 - 2026)

Fulgent Genetics' Change in Receivables history spans 12 years, with the latest figure at -$16.4 million for Q1 2026.

  • On a quarterly basis, Change in Receivables fell 463.2% to -$16.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.3 million, a 89.71% decrease, with the full-year FY2025 number at $23.3 million, up 42.62% from a year prior.
  • Change in Receivables hit -$16.4 million in Q1 2026 for Fulgent Genetics, down from $15.4 million in the prior quarter.
  • Over the last five years, Change in Receivables for FLGT hit a ceiling of $32.9 million in Q1 2022 and a floor of -$44.4 million in Q4 2022.
  • Historically, Change in Receivables has averaged -$2.8 million across 5 years, with a median of $1.6 million in 2024.
  • Biggest five-year swings in Change in Receivables: skyrocketed 404.85% in 2025 and later tumbled 463.2% in 2026.
  • Tracing FLGT's Change in Receivables over 5 years: stood at -$44.4 million in 2022, then surged by 111.72% to $5.2 million in 2023, then skyrocketed by 155.86% to $13.3 million in 2024, then increased by 15.4% to $15.4 million in 2025, then tumbled by 206.85% to -$16.4 million in 2026.
  • Business Quant data shows Change in Receivables for FLGT at -$16.4 million in Q1 2026, $15.4 million in Q4 2025, and -$4.9 million in Q3 2025.